Today, treatment of neovascular AMD with anti-vascular endothelial growth factors (anti-VEGFs) stabilizes or increases vision in most patients.3,4 The timing of cataract surgery is important in AMD patients; there is still debate regarding the effect of cataract surgery on AMD progression. This evidence concerns the gene VEGFA and age-related macular degeneration.